Jump to page content Accessibility
News, views and contacts from the global Drugdevelopment industry
Login to drugdevelopment-technology.com Log in or Register
  • Home
  • Products & Services
  • Company A - Z
  • Projects
  • Features
  • Videos
  • White Papers
  • News
  • Events
  • Advertise With Us
Industry Projects | Projects by Region | Projects by Category | Archived Projects | Project Gallery
 

Mylinax - Novel Therapy for the Treatment of



Serono's biotech research is centred on increasing understanding of naturally occurring proteins such as the immunomodulator interferon-beta.


  • Serono's biotech research is centred on increasing understanding of naturally...

  • Rebif (interferon-beta 1a) is the number one treatment for multiple sclerosis...

  • Rebif is given by subcutaneous (under the skin) injection and comes in...

  • Bioreactors, such as those used at Serono's Biotech Centre in Corsier Vevey,...

  • Geneva is the home of Serono, Europe's number one biotech company.

  • Aubonne, Switzerland, is one of Serono's leading centres for the manufacture...

  • Serono Biotech Centre (SBC) 2 in Corsier Vevey, Switzerland.

Back to Project Details



Related Projects

Ariflo (Cilomilast) - Oral PDE-IV Inhibitor for
Ariflo (cilomilast) is an oral selective phosphodiesterase (PDE) IV...

Fablyn (Lasofoxifene) - Investigational SERM
The product of a joint development programme between Pfizer and...

Rupintrivir -
Agouron Pharmaceuticals, a subsidiary of Pfizer, has pioneered...

Xolair - Biological Therapy
The product of a joint development programme between Tanox, Genentech...

Tarceva - Small Molecule
Tarceva (erlotinib) is an oral anti-cancer drug developed by...

See all projects


Contact us
Advertise with us
Terms and conditions
Privacy
Links
Newsletter sign up
Online magazine sign up

drugdevelopment-technology.com is a product of Net Resources International. Copyright 2011 Net Resources International, a trading division of SPG Media Limited.